Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Shtepa (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine). Impact of the phosphatidylcholine treatment program on the surfactant protein D levels in hypertensive patients with Acute Exacerbations of COPD. 187

Member's Comments

No comment yet.

Related content which might interest you: Influence the phosphatidylcholine treatment program on surfactant protein D levels in hypertensive patients with community-acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Value of adding treatment with lyophilized bacterial lysates in reducing COPD exacerbations in COPD patients risk group C and D Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Microparticles in stable and exacerbated COPD patients Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 High urea levels predict long term mortality in patients hospitalised for acute exacerbation of COPD Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Effects of a home-based pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease of GOLD D group. Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015